Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2882 | PRLD Prelude Therapeutics Incorporated - Common Stock | 6.67 USD | +0.60% | +17.02% | +71.91% | +421.09% | 532.29 M USD | ||
| 2889 | ARTV Artiva Biotherapeutics, Inc. - Common Stock | 11.25 USD | +2.93% | -4.98% | +12.61% | +170.43% | 550.01 M USD | ||
| 2895 | CABA Cabaletta Bio, Inc. - Common Stock | 3.09 USD | -1.28% | +5.82% | +12.36% | +88.41% | 523.90 M USD | ||
| 2898 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.33 USD | -3.27% | -10.42% | -11.17% | -42.13% | 530.05 M USD | ||
| 2920 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.23 USD | -2.26% | -5.07% | +10.32% | +111.03% | 508.97 M USD | ||
| 2923 | MPLT MapLight Therapeutics, Inc. - Common Stock | 11.31 USD | +0.89% | -1.65% | -11.71% | -40.47% | 524.53 M USD | ||
| 2939 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.97 USD | -0.75% | -5.25% | +16.42% | +53.28% | 488.41 M USD | ||
| 2950 | EVMN Evommune, Inc. Common Stock | 13.47 USD | -3.65% | -7.87% | +20.16% | -22.23% | 488.85 M USD | ||
| 2956 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.48 USD | -3.24% | -6.28% | -13.35% | +611.11% | 477.88 M USD | ||
| 2959 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.62 USD | +0.62% | +17.39% | +5.88% | -22.12% | 489.76 M USD | ||
| 2960 | PRTA Prothena Corporation plc - Ordinary Shares | 9.29 USD | -1.69% | +3.22% | +4.62% | +6.05% | 476.92 M USD | ||
| 2962 | RZLT Rezolute, Inc. - Common Stock | 4.94 USD | -2.95% | +5.78% | -0.20% | -29.43% | 475.68 M USD | ||
| 2968 | PBYI Puma Biotechnology Inc - Common Stock | 9.13 USD | -1.19% | +3.05% | +13.56% | +72.26% | 471.29 M USD | ||
| 2971 | EDIT Editas Medicine, Inc. - Common Stock | 3.05 USD | -1.93% | +6.64% | +15.97% | +8.16% | 468.42 M USD | ||
| 2979 | BNTC Benitec Biopharma Inc. - Common Stock | 13.00 USD | -3.56% | +1.40% | +12.07% | -21.73% | 446.61 M USD | ||
| 2982 | OCGN Ocugen, Inc. - Common Stock | 1.36 USD | -2.16% | 0.00% | +8.80% | +34.65% | 461.19 M USD | ||
| 3000 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.98 USD | -5.55% | +1.16% | -7.79% | -21.40% | 449.10 M USD | ||
| 3015 | AGMB AgomAb Therapeutics NV - ADRs representing one | 13.03 USD | -1.66% | -5.31% | +3.74% | -11.36% | 445.20 M USD | ||
| 3019 | EYPT EyePoint, Inc. - Common Stock | 5.01 USD | -5.83% | +10.84% | -59.86% | -58.25% | 431.92 M USD | ||
| 3030 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.40 USD | 0.00% | +1.69% | +13.74% | -20.27% | 432.21 M USD |
Haberler Biotechnology Stocks
Alto Neuroscience hissesi 35,42 dolarla rekor kırdı
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |